MESALAMINE | Allergan | ||
400mg; Capsule, Delayed Release |
Less Than $1000 mn
|
||
Less Than 5
|
Less Than 5
|
||
More Than 5
|
None | ||
Less Than 5
|
Less Than 5
|
||
Treatment of mildly to moderately active ulcerative colitis (UC) in patients 12 years of age and older and for the maintenance of remission of UC in adults. | |||
Yes
|
Delzicol | Patent 1 |
---|---|
**** | *** *** **** |
***** | ******* |
***** ****** | ******* |
Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
---|---|---|---|---|---|
**** | *** \ ** | *** **, **** | *** *** **** | ******** | ******** ** *** **, **** |
***** | ** \ ** | *** *, **** | ******* | **** | **** ******** |
***** ****** | ** \ ** | *** *, **** | ******* | **** | **** ******** |